India Malaria Diagnostics Market Size - Share Outlook, Growth Analysis Report and Forecast Trends 2026-2030

The India malaria diagnostics market encompasses products and services used to detect Plasmodium parasites in patient samples, including rapid diagnostic tests, microscopy tools, and molecular assays. The market sits within the global malaria diagnostics sector valued at approximately $0.9 billion in 2025, with India representing a significant share of the Asia-Pacific region. Despite India's progress in reducing malaria burden, the country still reports a substantial number of cases annually, sustaining demand for diagnostic solutions across public and private healthcare channels.

• •Market valued between $30.2 million and $52 million in 2025 depending on scope and methodology
• •Projected CAGR of 4.4-5% through 2030-2034
• •Driven by government programs like the National Framework for Malaria Elimination

India's commitment to eliminating malaria by 2030 under the National Strategic Plan has accelerated investment in diagnostic capacity, particularly in high-burden states across the northeast and central regions. International funding from the Global Fund and bilateral agencies supports procurement of diagnostics, while domestic health budgets increasingly allocate resources toward vector-borne disease control. The need for accurate diagnosis to support targeted treatment, reduce drug resistance, and meet WHO certification requirements continues to expand market demand.

• •National Malaria Elimination Program expanding diagnostic access in rural and tribal areas
• •WHO recommendations favoring RDT-based diagnosis over presumptive treatment
• •Growing private laboratory sector and rising healthcare expenditure

The market is broadly segmented by product type into rapid diagnostic tests, microscopy supplies, and molecular/PCR-based products, with RDTs holding the largest share due to ease of use in field settings. By end-user, the market splits among government health facilities, private hospitals and clinics, and diagnostic laboratories. Geographically, high malaria incidence in states such as Odisha, Chhattisgarh, Jharkhand, and the northeastern states drives regional demand, while urban centers show stronger growth in molecular diagnostics.

• •Point-of-care rapid diagnostic tests represent the dominant product category
• •Immunochromatographic tests for P. falciparum and P. vivax are most widely deployed
• •Eastern and northeastern India account for highest diagnostic volume

What are the recent trends and outlook?

Integration of digital health tools with malaria diagnostics is emerging, including smartphone-readable RDTs and electronic reporting systems that connect field data to surveillance platforms. Advances in molecular diagnostics are enabling detection of low-density infections and drug-resistance markers, though cost remains a barrier for widespread adoption. The market is expected to maintain steady growth as India pursues its elimination goals, with potential upside from new product launches, public-private partnerships, and expanded screening programs targeting vulnerable populations.

• •Multiplex diagnostic panels combining malaria with other febrile illnesses gaining attention
• •GeneXpert and other NAAT platforms being evaluated for malaria in reference laboratories
• •Domestic manufacturing push under PLI scheme may increase local supply and reduce costs